MOREPENLAB / NSE / Biotechnology & Drugs
Morepen Laboratories
1Y Price Trend
Key Information
Recommendations
Target High70.4
Target Low33.44
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk48.51
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Manipal Hospital Bhubaneswar saves 3-year-old from rare congenital spinal disorder ODISHA RAY
Why Morepen Laboratories Share Price is Rising Equitymaster
Morepen Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns Markets Mojo
NGT issues notice to Morepen plant in Kasauli over noise pollution MSN
Morepen Laboratories Downgraded to Strong Sell Amid Financial and Valuation Concerns Markets Mojo
Morepen Laboratories Q4 net profit falls 22.7 pc to Rs 15.70 cr MSN
Morepen Laboratories Q4 net profit falls 22.7 pc to Rs 15.70 cr MSN
VIT Bhopal adds preventive care layer with Dr. Morepen Prittle Prattle News
© SharekeyX | Rusaka Technologies 2024-2026